<i>In vitro</i> validations revealed that SFXN3 knockdown substantially impairs cell proliferation while simultaneously sensitizing HNSCC cells to cisplatin-induced apoptosis via intrinsic pathways. The gene discussed is SFXN3; the disease is head and neck squamous cell carcinoma.